NET (NET) shareholder files Rule 144 to sell 134 common shares
Rhea-AI Filing Summary
NET received a Rule 144 notice from a shareholder planning a small sale of common stock. The filing covers a proposed sale of 134 common shares through Morgan Stanley Smith Barney LLC on or about 01/02/2026, with an aggregate market value of $26,652.60. The filing notes that 315,250,214 common shares were outstanding. The 134 shares to be sold were acquired as restricted stock from the issuer on 06/01/2024.
The notice also lists prior activity over the past three months for the same seller, Mark Hawkins. It reports sales of 134 common shares on 12/01/2025 for $26,485.10 and 1,000 common shares on 11/03/2025 for $254,150.00. By signing, the seller represents that he is not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
FAQ
What does the latest Rule 144 filing for NET disclose?
The filing shows a shareholder has filed notice to sell 134 common shares of NET on or about 01/02/2026 through Morgan Stanley Smith Barney LLC, with an aggregate market value of $26,652.60.
How many NET shares are planned to be sold under this Rule 144 notice?
The Rule 144 notice covers a proposed sale of 134 shares of NET common stock, using Morgan Stanley Smith Barney LLC as broker.
How many NET shares were outstanding according to this Rule 144 notice?
The notice states that there were 315,250,214 NET common shares outstanding at the time referenced in the filing.
When and how were the NET shares being sold under Rule 144 originally acquired?
The 134 NET common shares were acquired on 06/01/2024 as restricted stock from the issuer, with payment described as Not Applicable.
What NET share sales has the filer made in the last three months?
The filer, Mark Hawkins, sold 134 NET common shares on 12/01/2025 for $26,485.10 and 1,000 shares on 11/03/2025 for $254,150.00.
What representation does the NET Rule 144 seller make about inside information?
By signing the notice, the seller represents that he does not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.